Carcinoid Tumor Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials

Telotristat Ethyl for the Treatment of Carcinoid Heart Disease in Patients With Metastatic Neuroendocrine Tumor
Conditions:   Locally Advanced Well Differentiated Neuroendocrine Neoplasm;   Metastatic Well Differentiated Neuroendocrine Neoplasm Interventions:   Drug: Placebo Administration;   Other: Questionnaire Administration;   Drug: Telotristat Ethyl Sponsor:   M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2021 Category: Research Source Type: clinical trials